KLK3 | Kallikrein-related peptidase 3 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
TGM4 | Transglutaminase 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
RLN1 | Relaxin 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK2 | Kallikrein-related peptidase 2 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACPP | Acid phosphatase, prostate | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
KLK4 | Kallikrein-related peptidase 4 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CHRNA2 | Cholinergic receptor, nicotinic, alpha 2 (neuronal) | Disease related genes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
SLC45A3 | Solute carrier family 45, member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Tissue enriched |
MSMB | Microseminoprotein, beta- | Cancer-related genes Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
OR51E2 | Olfactory receptor, family 51, subfamily E, member 2 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enriched |
SP8 | Sp8 transcription factor | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
STEAP2 | STEAP family member 2, metalloreductase | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
NEFH | Neurofilament, heavy polypeptide | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
RFPL2 | Ret finger protein-like 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
NCAPD3 | Non-SMC condensin II complex, subunit D3 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enriched |
NKX3-1 | NK3 homeobox 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
TBL1Y | Transducin (beta)-like 1, Y-linked | Predicted intracellular proteins
| | | | | Tissue enriched |
RDH11 | Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
TRPM8 | Transient receptor potential cation channel, subfamily M, member 8 | FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enriched |
COL9A1 | Collagen, type IX, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enriched |
SLC30A4 | Solute carrier family 30 (zinc transporter), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |